- Conditions
- Vaccines, Meningococcal Vaccines
- Interventions
- rLP2086 + MCV4 + Tdap, MCV4 + Tdap + saline, rLP2086 + saline
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 10 Years to 12 Years
- Enrollment
- 2,648 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2014
- U.S. locations
- 117
- States / cities
- Birmingham, Alabama • Daphne, Alabama • Chandler, Arizona + 73 more
Source: ClinicalTrials.gov public record
Updated Dec 19, 2018 · Synced May 22, 2026, 3:54 AM EDT